Dr. Yaxia Zhang is the Associate Chief Clinical Pathologist in the HSS Department of Pathology and Laboratory Medicine. Dr. Zhang comes to HSS from Cleveland Clinic, where she practiced in the Department of Pathology as orthopedic pathologist, molecular cytopathologist from 2013-2017.
Dr. Zhang specializes in non-neoplastic and neoplastic orthopedic pathology, and molecular cytopathology, especially investigating the molecular mechanisms of orthopedic diseases. She is also interested in success and failure of reconstructive orthopedic procedures, devices and bone graft substitute materials.
Non-neoplastic and neoplastic orthopedic pathology
Reconstructive orthopedic procedures, devices and bone graft substitute materials
Interpretation of bone, joint, soft tissue and general surgical pathology specimens
Evaluation of retrieved orthopedic devices
All laboratory medicine (excluding blood banking)
Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may have coverage subject to the availability of 'out-of-network' benefits.
Associate Chief Clinical Pathologist, Hospital for Special Surgery
Associate Attending Pathologist, Hospital for Special Surgery
Associate Professor of Pathology and Laboratory Medicine, Weill Cornell Medical College
Orthopedic Research Society
International Skeletal Society
College of American Pathologists
United States and Canadian Academy of Pathology
American Society of Cytopathology
Anatomic and Clinical Pathology, 2011
Molecular Genetic Pathology/Orthopedic Pathology, 2013
Mentor for the 1st, 2nd resident abstract competition awards at the Cleveland Society of Pathology (CSP), 2016
Award on Musculoskeletal (Bone Intervention), Radiological Society of North America (RSNA) (Co-author), 2016
Outstanding Original Investigation by American Association for Bronchology and Interventional Pulmonology (Co-author), 2016
3th Annual Zubrod Clinical/Translational Research Award, Sylvester Comprehensive Cancer Center, University of Miami, 2012
Zhejiang University, School of Medicine, 1997
University of Miami, Miller School of Medicine, 2005
University of Miami, Jackson Memorial Hospital, 2011
University of Miami, Jackson Memorial Hospital, 2013
Marilyn Bui, Yaxia Zhang, Evita Henderson-Jackson. Chapter: Bone. Boo: Grossing, Staging and Reporting- and integration of modern surgical pathology. CAP Press. 2021.
Yaxia Zhang and Andrew E. Rosenberg. Chapter 35-39 and 85. Tumors and Tumors-Like Lesions of Bone, 2nd edition, p483-523. Springer 2020.
Xiaohua Qiang and Yaxia Zhang. Practical Cytopathology: Frequently Asked Questions. Chapter 17 Soft Tissue and Bone. Springer Nature. 2020.
Zhang Y. Chapter 12-Molecular markers of soft tissue and bone tumors. Molecular Cytopathology. Springer Switzerland, 2016.
Zhang Y. Rosenberg A, Marilyn Bui, et al. Primary Bone Vascular Tumors. Arch pathol Lab med. Submitted. 2021.
Curcio CA, Bauer TW, Mintz ND, Bogner EA, Zhang Y. Monoarticular multifocal tenosynovial giant cell tumours are associated with higher local recurrence rate. Arch Pathol Lab Med Submitted. 2021.
Zhang W, Yao J, Zong M, Zhang Y, Guo X, Wang HY. A Brief Overview and Update on Molecular Pathology on Bone, Solid, Soft, and Hematologic Tumours. Arch Pathol Lab Med. Accepted. 2021.
Showalter K., Spiera R., Magro C., Agius, P., Martyanov V., Franks J., Sharma R., Geiger H., Wood T., Zhang Y., Finik J., Whitfield M.L., Orange D.E., Gordon J.K. Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarization as a hallmark of clinical severity and improvement. Ann Rheum Dis. 2021 Feb;80(2):228-237.
Showalter K, Magro C, Zhang Y, Spiera R, Orange DE, Gordon JK. Response to: “Correspondence on “Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement” by Manetti. Ann Rheum Dis. 2020 Nov 6:annrhemadis-2020-219292.
Lu H, Allende Daniela, Liu X, and Zhang Y. LEF1 and PAX8: A Limited Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors. Appl Immunohistochem Mol Morphol. 2020 Nov/Dec;28(10):776-780.
Lu H, Elsheikh TM, and Zhang Y. BK virus cytopathic effect in urine cytology is not associated with high risk of developing high grade urothelial carcinoma. J Am Soc Cytopathol. 2020 Mar-Apr;9(2):84-88.
Yuan L, Biscotti CV, Zhu H, Booth CN, Abdul-Karim FW, Zhang Y. Significance of atypical endometrial cells in women younger than 40 years of age. J Am Soc Cytopathol. 2020 Jan-Feb;9(1):33-37.
Kuyumcn G, Zhang Y, Ilaslan H. Case 272: Decubital Ischemic Fasciitis. Radiology. 2019 Dec;292 (3): 721-724.
Doxtader EE, Cheng YW, Zhang Y. Molecular Testing of Non-Small Cell Lung Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Fine-Needle Aspiration: The Cleveland Clinic Experience. Arch Pathol Lab Med. 2019 Jun;143(6):670-676.
Showalter K., Orange D., Zhang, Y., Spiera, R., Whitfield, M, Gordon, J. CD34 and alpha-smooth muscle actin distinguish scleroderma gene expression subsets using a machine learning approach. Abstract for poster presentation. Systemic Sclerosis World Congress Meeting, Prague, Czech Republic, July 2020. https://journals.sagepub.com/doi/full/10.1177/2397198319898367, P011.
Showalter K., Spiera R., Magro C., Agius, P., Martyanov V., Franks J., Sharma R., Geiger H., Wood T., Zhang Y., Finik J., Whitfield M.L., Orange D.E., Gordon J.K. Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarization as a hallmark of clinical severity and improvement. Abstract for oral presentation. Hospital for Special Surgery Clinical Fellow Research Podium Presentations, New York, NY, 2020. (Awarded the Charles L. Christian Award for Excellence in Musculoskeletal Research).
Curcio CA, Schneider R, Savelyev R, Bauer TW, Zhang Y. Clinical, Radiographic, and Pathologic Analysis of Total Hip Arthroplasty in Patients with Legg-Calvé-Perthes Disease. Abstract accepted by 109th USCAP Annual Meeting, Los Angeles, CA.2020.
Curcio CA, Bauer TW, Zhang Y. Mono-Articular Multifocal Localized Tenosynovial giant Cell Tumors. Abstract accepted by 109th USCAP Annual Meeting, Los Angeles, CA.2020.
Bauer TW, Zhang Y. Gao M, Sternberg J, Lin B, Koff MF. Reproducibility of pathologic scoring systems for revision total hip arthroplasty. Abstract accepted for ORS 2020 annual meeting, Pheonix, AZ, 2020.
Showalter KF, Spiera R, Orange D, Margro C, Zhang Y, et al. Change in Scleroderma Skin Correlates with the Combined Response Index in Systemic Sclerosis (CRISS) in Patients with Early, Diffuse Cutaneous Systemic Sclerosis. Oral Presentation at the ACR/ARP Annual Meeting, Atlanta, GA, November 8-13.2019.
Showalter K, Magro C, Zhang Y, et al. Beneath the skin Score: Correlating skin histologic features with clinical data in patients with early, diffuse cutaneous systemic sclerosis. Poster Presentation at the 2019 ACR/ARP Annual Meeting, Atlanta, GA, November 8-13. 2019.
Showalter KF, Margro C, Orange D, Zhang Y, et al. Histologic Features Correlate with the Modified Rodnan Skin Score, Serum Inflammatory Markers, and Patient Reported Outcomes in patients with Early, Diffuse Cutaneous Systemic Sclerosis. Poster Presentation at the 2019 ACR/ARP Annual Meeting, Atlanta, GA, November 8-13, 2019.
Zhang Y, Bauer TW, and Rodeo S. Pseudotumour Formation Next to Tibial Tunnel Bioabsorbable Screw in a Patient with Congenital Absence of the Anterior Cruciate Ligament. International Skeletal Society Annual Meeting, Vancouver, Ca, Oral E-PPT Presentation. September 2019.
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of November 13, 2019, Dr. Zhang reported no relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.